Therapeutic Advances in Infectious Disease
@TAInfDis
Followers
1K
Following
1K
Media
161
Statuses
1K
A SAGE Open Access journal | Publishing high-quality articles in infectious disease | Editor-in-Chief @andhen25 | IF 3.8
SAGE Publishing, London
Joined February 2020
📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. @andhen25
https://t.co/vpg2oEHBqQ
journals.sagepub.com
View articles in this Published Special Issue of Therapeutic Advances in Infectious Disease
0
1
1
Novel entomo-virological tools, such as honey-baited traps preserving mosquito-expectorated RNA, are reshaping arbovirus monitoring. Integrating these with genomic surveillance can bridge field ecology and molecular epidemiology. 🔬🦟 https://t.co/5V2UANzW9y
journals.sagepub.com
Arthropod-borne viruses (arboviruses) represent a major public health burden for people living or visiting tropical and subtropical countries, where an endemic/...
0
1
2
P. aeruginosa is the archetype of adaptive resistance—porins close, pumps activate, enzymes evolve. New β-lactam/β-lactamase inhibitor combos and cefiderocol offer treatment options. https://t.co/m4G2TMJBQr
journals.sagepub.com
Pseudomonas aeruginosa is one of the most clinically important Gram-negative bacteria and is related to many severe and life-threatening infections worldwide. I...
0
1
1
Retrospective time-series study (2014–2019, Mysuru, India): Rising temperature, humidity, and monsoon rainfall were linked to increased Salmonella bacteraemia. Findings suggest climate–infection interplay with implications for AMR trends. https://t.co/kcG6Kv9L7Q
journals.sagepub.com
Background: Salmonella species are major pathogens responsible for gastroenteritis and typhoid fever. In 2017, Salmonella enterocolitis caused over 95 million ...
0
1
2
Meta-analysis (7 studies, n=1685): Cefazolin vs. ASPs for MSSA endocarditis — similar efficacy, lower 30-day mortality (OR 0.49, 95% CI 0.29–0.83), and fewer adverse events. Supports cefazolin as a viable alternative https://t.co/1PJu3HBuAc
journals.sagepub.com
Background: Methicillin-susceptible Staphylococcus aureus (MSSA) is a leading cause of infective endocarditis (IE), associated with high morbidity and mortality...
0
1
2
🚨study from Bolivia: A novel PCR platform—Orange G3 TBC—shows comparable accuracy to GeneXpert Ultra for TB diagnosis (sensitivity = 90%, specificity = 97%). Its biosafe, low-resource–friendly design could expand TB testing access in endemic settings. https://t.co/KtdNrXMKft
journals.sagepub.com
Background: Tuberculosis (TB) remains a global public health priority, with 10.5 million new cases and 1.5 million deaths reported in 2023. Current diagnostic m...
0
2
2
Excited to see everyone at #IDWeek2025! Catch the @TAInfDis team sharing insights across these great sessions.
0
1
3
A systematic review (2003–2023) shows live attenuated (LAIV) and inactivated (IIV) influenza vaccines protect children/adolescents equally well (~50% VE). Post-2017 LAIV strain updates restored H1N1 protection and improved efficacy vs influenza B. https://t.co/f4kgTo0K1I
journals.sagepub.com
Summary What is this summary about? This is a plain language summary describing the results of a systematic literature review and meta-analysis originally publ...
0
1
1
In a survey of 128 HIV care workers, negative attitudes toward people who use drugs were strongly linked to lower acceptance of harm reduction practices. Acceptance varied by site, race, and experience—pointing to structural and training gaps. https://t.co/L18R6iB5Zo
journals.sagepub.com
Background: Negative attitudes toward people who use drugs (PWUD) can hinder their engagement in healthcare and contribute to poor clinical outcomes. While harm...
0
1
2
Dolutegravir/lamivudine improved quality of life, treatment acceptability, and symptom burden in PLWH over 6 months (French multicenter study, n=260). Gains appeared by month 1 and persisted. Monitoring discontinuations—especially among women—remains key. https://t.co/VSYEtFfVTB
journals.sagepub.com
Background: Simplification of antiretroviral regimens has the potential to improve both patient-reported outcomes (PROs) and therapeutic adherence in people liv...
0
1
1
🚨 Submission Open! 🚨 🦠Antimicrobial Resistance Mechanisms & Therapeutic Options for Difficult-to-treat Nosocomial Pathogens 🌍 📅 Deadline: Dec 31, 2025 📚 Submissions are now welcome! For full details, check out the link. https://t.co/Gz2gS78qI5
journals.sagepub.com
View articles in this Published Special Issue of Therapeutic Advances in Infectious Disease
0
1
1
Systematic review/meta-analysis (2013–2024, n=23,319): In febrile neutropenia after chemotherapy, bloodstream infections were 59% Gram-negative, 39.7% Gram-positive, and 2.5% fungal. https://t.co/vzaJ30J6D4
journals.sagepub.com
Background: Febrile neutropenia (FN) is the most common and serious adverse event of chemotherapy for solid and hematological neoplasms, with infection as a maj...
0
2
2
📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. @andhen25
https://t.co/vpg2oEHBqQ
journals.sagepub.com
View articles in this Published Special Issue of Therapeutic Advances in Infectious Disease
0
2
4
The Clade IIb #mpox 🌍 outbreak exposed major gaps in evidence for antivirals 💊, vaccine equity 💉, and surveillance. This review maps the path toward targeted, evidence-based treatments and prevention✨ https://t.co/OkXXbeE8pN
journals.sagepub.com
The resurgence of monkeypox (mpox), driven by Clade IIb of the monkeypox virus (MPXV), has intensified global concerns about its transmission, treatment, and pr...
0
1
1
ED study in Japan: Relaxation of COVID-19 IPC practices led to a surge in virus-related exacerbations of COPD (7.7%→52.5%) & asthma (39.7%→66.7%). Reinforcing viral prevention is key in chronic airway disease care. https://t.co/IOyyw3K8EZ
journals.sagepub.com
Background: Infection prevention and control (IPC) measures during the coronavirus disease 2019 (COVID-19) pandemic have led to a reduction in respiratory viral...
0
2
3
📊 HIV from injection drug use is climbing (2016–2022). PrEP uptake in PWID remains critically low. Call to action: integrate ID + addiction care, expand low-barrier services, implement LA-PrEP, and fight stigma through policy + education. https://t.co/BQynfbmmTs
journals.sagepub.com
New human immunodeficiency virus (HIV) cases related to injection drug use (IDU) in the United States increased between 2016 and 2022. The uptake of preexposure...
0
0
3
Hospital clinician training transformed care for PWUD w/ severe infections. Post-training: 95% applied harm reduction (vs 55%), 69% discussed safer use (vs 38%). https://t.co/8WNbcP4nUj
journals.sagepub.com
Background: People who use drugs (PWUD) are at increased risk for severe infections and face many barriers when completing conventional, typically parenteral an...
0
1
2
📊 East Jerusalem hospital study (2019–2023): CRE in 20.6% of Enterobacterales isolates; blaNDM dominated (82%), blaOXA-48 (13%). Prevalence rising, Klebsiella most common.
journals.sagepub.com
Background: Carbapenem-resistant Enterobacterales (CRE) are a significant public health threat affecting human health globally. Unfortunately, the incidence of ...
0
1
1
🚨 Submission Open! 🚨 🦠Antimicrobial Resistance Mechanisms & Therapeutic Options for Difficult-to-treat Nosocomial Pathogens 🌍 📅 Deadline: Dec 31, 2025 📚 Submissions are now welcome! For full details, check out the link. https://t.co/Gz2gS78qI5
journals.sagepub.com
View articles in this Published Special Issue of Therapeutic Advances in Infectious Disease
0
0
1
Despite free HIV care & PrEP in Peru, HIV incidence among youth remains high (13% at age 18; 25% in trans youth <18). Restricting PrEP to 18+ misses a critical window. Peru must expand PrEP to 15–17-year-olds. https://t.co/sVB0dw8yz2
journals.sagepub.com
0
0
0